Risks of all-cause death and completed suicide in patients with schizophrenia/schizoaffective disorder treated with long-acting injectable or oral antipsychotics: A population-based retrospective cohort study in Taiwan.
Chao Hsiun TangShih-Pei ShenMin-Wei HuangHong QiuSayuri WatanabeChoo Hua GohYanfang LiuPublished in: European psychiatry : the journal of the Association of European Psychiatrists (2021)
No increased risk of all-cause death or completed suicide was observed in users of antipsychotic LAIs, including PP1M and PP3M.